Publications by authors named "Jessica Konen"

Claim this Profile
I
Immune checkpoint blockade resistance in lung cancer: emerging mechanisms and therapeutic opportunities.
Jessica M Konen, Haoyi Wu, Don L Gibbons

Trends Pharmacol Sci· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Directions to overcome therapy resistance in cancer.
Ruth Nussinov, Thomas Weichhart, Zodwa Dlamini, Don L Gibbons, Isabelle Van Seuningen, Jessica Konen

Trends Pharmacol Sci· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A live-cell platform to isolate phenotypically defined subpopulations for spatial multi-omic profiling.
Tala O Khatib, Angelica M Amanso, Christina M Knippler, Brian Pedro, Emily R Summerbell, Jessica M Konen

PLoS One· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autotaxin suppresses cytotoxic T cells via LPAR5 to promote anti-PD-1 resistance in non-small cell lung cancer.
Jessica M Konen, B Leticia Rodriguez, Haoyi Wu, Jared J Fradette, Laura Gibson

J Clin Invest· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting immunosuppressive Ly6C+ classical monocytes reverses anti-PD-1/CTLA-4 immunotherapy resistance.
B Leticia Rodriguez, Limo Chen, Yanli Li, Shucheng Miao, David H Peng, Jessica M Konen

Front Immunol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A live-cell platform to isolate phenotypically defined subpopulations for spatial multi-omic profiling.
Tala O Khatib, Angelica M Amanso, Brian Pedro, Christina M Knippler, Emily R Summerbell, Jessica M Konen

bioRxiv· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting CDK4 overcomes EMT-mediated tumor heterogeneity and therapeutic resistance in KRAS-mutant lung cancer.
Aparna Padhye, Jessica M Konen, B Leticia Rodriguez, Jared J Fradette, Joshua K Ochieng

JCI Insight· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Th17 cells contribute to combination MEK inhibitor and anti-PD-L1 therapy resistance in KRAS/p53 mutant lung cancers.
David H Peng, B Leticia Rodriguez, Lixia Diao, Pierre-Olivier Gaudreau, Aparna Padhye, Jessica M Konen

Nat Commun· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual Inhibition of MEK and AXL Targets Tumor Cell Heterogeneity and Prevents Resistant Outgrowth Mediated by the Epithelial-to-Mesenchymal Transition in NSCLC.
Jessica M Konen, B Leticia Rodriguez, Aparna Padhye, Joshua K Ochieng, Laura Gibson

Cancer Res· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic significance of an invasive leader cell-derived mutation cluster on chromosome 16q.
Brian Pedro, Manali Rupji, Bhakti Dwivedi, Jeanne Kowalski, Jessica M Konen

Cancer· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epigenetically heterogeneous tumor cells direct collective invasion through filopodia-driven fibronectin micropatterning.
Emily R Summerbell, Janna K Mouw, Joshua S K Bell, Christina M Knippler, Brian Pedro, Jessica Konen

Sci Adv· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Good, the Bad and the Unknown of CD38 in the Metabolic Microenvironment and Immune Cell Functionality of Solid Tumors.
Jessica M Konen, Jared J Fradette, Don L Gibbons

Cells· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic heterogeneity within collective invasion packs drives leader and follower cell phenotypes.
Elizabeth L Zoeller, Brian Pedro, Jessica Konen, Bhakti Dwivedi, Manali Rupji

J Cell Sci· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting the Interplay between Epithelial-to-Mesenchymal-Transition and the Immune System for Effective Immunotherapy.
Rama Soundararajan, Jared J Fradette, Jessica M Konen, Stacy Moulder, Xiang Zhang

Cancers (Basel)· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Ntrk1 Promotes Resistance to PD-1 Checkpoint Blockade in Mesenchymal Kras/p53 Mutant Lung Cancer.
Jessica M Konen, B Leticia Rodriguez, Jared J Fradette, Laura Gibson, Denali Davis

Cancers (Basel)· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TASI: A software tool for spatial-temporal quantification of tumor spheroid dynamics.
Yue Hou, Jessica Konen, Daniel J Brat, Adam I Marcus, Lee A D Cooper

Sci Rep· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The complex ecosystem in non small cell lung cancer invasion.
Seth Haney, Jessica Konen, Adam I Marcus, Maxim Bazhenov

PLoS Comput Biol· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vimentin Is Required for Lung Adenocarcinoma Metastasis via Heterotypic Tumor Cell-Cancer-Associated Fibroblast Interactions during Collective Invasion.
Alessandra M Richardson, Lauren S Havel, Allyson E Koyen, Jessica M Konen, John Shupe

Clin Cancer Res· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting adhesion signaling in mutant lung adenocarcinoma.
Melissa Gilbert-Ross, Jessica Konen, Junghui Koo, John Shupe, Brian S Robinson

JCI Insight· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Local alignment vectors reveal cancer cell-induced ECM fiber remodeling dynamics.
Byoungkoo Lee, Jessica Konen, Scott Wilkinson, Adam I Marcus, Yi Jiang

Sci Rep· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LKB1 kinase-dependent and -independent defects disrupt polarity and adhesion signaling to drive collagen remodeling during invasion.
Jessica Konen, Scott Wilkinson, Byoungkoo Lee, Haian Fu, Wei Zhou

Mol Biol Cell· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis